We are live on ! Find out more
NP

Newlight Partners Portfolio holdings

AUM $3.9M
1-Year Est. Return 96.05%
This Fund
S&P 500
This Quarter Est. Return
-33.5%
1 Year Est. Return
-96.05%
3 Year Est. Return
-92.84%
5 Year Est. Return
-96.09%
10 Year Est. Return
–
AUM
$939M
AUM Growth
-$537M
Cap. Flow
-$40.5M
Cap. Flow %
-4.31%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HRMY icon
Harmony Biosciences
HRMY
+$29.3M
2
OWL icon
Blue Owl Capital
OWL
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 70.9%
2 Financials 16.26%
3 Technology 12.76%
4 Consumer Staples 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSH
1
DELISTED
Oak Street Health, Inc.
OSH
$666M 70.89%
40,509,640
– –
OWL icon
2
Blue Owl Capital
OWL
$8.29B
$153M 16.26%
15,228,327
-934,446
-6% -$11.2M
NOVA
3
DELISTED
Sunnova Energy
NOVA
$120M 12.76%
6,505,811
– –
LAUR icon
4
Laureate Education
LAUR
$5.36B
$769K 0.08%
66,442
– –
HRMY icon
5
Harmony Biosciences
HRMY
$2.31B
$7K ﹤0.01%
151
-651,221
-100% -$29.3M

Similar funds

BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return

Newlight Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Newlight Partners held 5 positions worth $939M, down 36% from $1.48B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Newlight Partners withdrew a net $40.5M in Q2 2022, reducing 2 holdings. Its largest reduction was Harmony Biosciences, cutting an estimated $29.3M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 76% a quarter earlier, followed by Financials and Technology.

  • Newlight Partners's biggest Q2 2022 reduction was Harmony Biosciences, cutting an estimated $29.3M.
  • Newlight Partners's ten largest holdings make up 100% of its $939M portfolio in Q2 2022.
  • Newlight Partners opened 0 new positions and closed 0 in Q2 2022.
  • Newlight Partners's portfolio value fell 36% quarter-over-quarter to $939M.

Based on Newlight Partners's 13F filing for Q2 2022, filed 15 Aug 2022.